Home
The Department of Biomedicine

News archive for The Department of Biomedicine

Open for registration, deadline 20th of February.
Interesting meeting in Molecular Imaging in Cologne, Germany, 05-07.04.2017
The molecular processes of myelin maturation are to a large extent still unknown. A coordinated interplay between regulatory and functional molecules must take place for correct timing of myelin membrane apposition and compaction, such that cytoplasmic channels are also formed in a correct way.
A new system for confocal and super-resolution imaging avalible at MIC.
Auroras work at USC highlighted in the J1 Newsletter.
Professor Jan Haavik has been given the Helse Vest Research award 2016 for his research on discovering biological mechanisms that can cause ADHD-symptoms. He was rewarded the prize during the annual research conference of Helse Vest.
Welcome to the mini-seminar 3rd of November in Aud. 2, BBB, 1330-1530 and the inauguration of MICs new Confocal/STED microscope: Leica TCS SP8 STED 3X
Bio3D-web is a new online tool for the analyses of sequence, structure and conformational heterogeneity of protein families. The tool is developed by researcher Dr. Lars Skjærven, member of the the Biorecognition group, in collaboration with Prof. Barry J. Grant at the University of Michigan.
Biorecognition won the Faculty of Medicine and Dentistry prize for best research group.
MIC is happy to announce the 12th course in confocal microscopy 1st - 4th of March 2016. Registration is now open and we encourage you to register as soon as possible as it tends to fill up quickly, deadline 12th of February. Max. 18 participants.
Children of mothers with diseases like asthma or arthritis have up to eighty per cent higher risk of developing ADHD.
A network seminar series to promote collaboration between Nordic countries in biological and medical imaging. 2nd seminar in Gotheburg, Sweden, 14th-15th of April 2016.
The Biorecognition group at the Department of Biomedicine represents one of the four nodes in the new NOR-Openscreen infrastructure. The infrastructure will support the discovery of biologically active substances in all areas of the Life Sciences by providing transnational, open access to the most advanced technologies, chemical and biological resources as well as expertise through Europe.

Pages